Sign in
Not yet recruitingNo phase

CLEAR Trial: CA330 Cytokine Adsorption Column for Anticoagulant/Antiplatelet Patients in Non-Elective CPB Surgery.

Key facts

Who runs it
Beijing Anzhen Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
120 people, planned
Started
15 Dec 2025
Expected to end
30 Jun 2028
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • CA330 Cytokine Adsorption Column
Record updated
16 December 2025

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Patients scheduled to undergo non-elective cardiovascular surgery requiring cardiopulmonary bypass
  • Patients currently receiving one or more of the following medications - indobufen, ticagrelor, warfarin, cilostazol, dabigatran, rivaroxaban, or apixaban - with the last dose administered within the drug washout period

Who cannot take part

  • Patients with a history of chronic liver failure, stage 5 chronic kidney disease (CKD5), or requiring regular dialysis
  • Patients with advanced-stage malignancy or scheduled cardiovascular surgery related to tumor management
  • Patients with allergic reactions to cytokine adsorption column resin or related components
  • Patients with known bleeding risk due to hematologic disorders such as heparin-induced thrombocytopenia, hemophilia, or acute sickle cell crisis
  • Patients with severe infection, including severe sepsis
  • Patients in special physiological states: pregnancy or puerperium

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to evaluate whether the CA330 cytokine adsorption column can reduce perioperative severe bleeding adverse events in patients receiving anticoagulant and/or antiplatelet therapy who undergo non-elective cardiac surgery with cardiopulmonary bypass.

Read full original descriptionShow less

The main questions it aims to answer are:

* Does the use of the CA330 cytokine adsorption column lower the incidence of perioperative severe bleeding compared with standard care? * Does the intervention improve short-term clinical outcomes, such as transfusion requirements, reoperation rates for bleeding, or overall postoperative recovery?

If there is a comparison group: Researchers will compare patients treated with the CA330 cytokine adsorption column versus patients receiving standard cardiopulmonary bypass management to see if cytokine adsorption provides additional safety and efficacy benefits.

Participants will:

* Undergo non-elective cardiac surgery requiring cardiopulmonary bypass. * Be randomly assigned to receive either the CA330 cytokine adsorption column integrated into the CPB circuit (intervention arm) or standard CPB management without the device (control arm). * Be monitored for perioperative bleeding outcomes, transfusion needs, reoperation rates, and overall postoperative prognosis.

The 2 groups in the trial

  • CA330 GroupTreatment being tested

    CA330 Cytokine Adsorption Column and Standard Cardiopulmonary Bypass Management

    Treatment: CA330 Cytokine Adsorption Column

  • non-CA330 GroupNo study treatment, for comparison

    Standard Cardiopulmonary Bypass Management Alone

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Multicenter Randomized Controlled Trial of the CA330 Haemoadsorption Device in Patients for Limiting Excess Anticoagulation in Non-elective caRdiac Surgery With Cardiopulmonary Bypass
Criteria questions
Built from NCT07284199, who can take part
Record updated
16 December 2025